RFI-621-21-HO-001: Tanzania Malaria Case Management Activity (TMCM)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Tanzania USAID-Dar es Salaam notices from 2021.
Tanzania USAID-Dar es Salaam offered grants to any type of organization. It expected to make one award worth $45.0 million in total. Applications closed on September 15, 2021.
From the official notice on Grants.gov, last changed February 28, 2022. Checked November 7, 2026.
- Total funding$45.0 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| 72062122RFA00004 | February 28, 2022 | Closed April 14, 2022 | Closed |
Key dates
| Posted | August 30, 2021 |
|---|---|
| Deadline | September 15, 2021 |
| Archived by Grants.gov | October 15, 2021 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Is this a realistic fit?
- Most of the program's money (54% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The United States Agency for International Development (USAID) Mission in Dar es Salaam, Tanzania posts this Request for Information (RFI) to seek input from capable and interested International and Local organizations for an upcoming health office activity designed to support the Government of Tanzania (GOT) to reduce the burden of malaria and move towards the long-term goal of malaria elimination. A five-year activity under a Cooperative Agreement mechanism is anticipated.
Who has won USAID Foreign Assistance for Programs Overseas grants before
From fiscal 2021 to 2025, USAID Foreign Assistance for Programs Overseas (98.001) awarded $37 billion across 4,233 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Miscellaneous Foreign Awardees | District of Columbia | 489 | $6.9 billion |
| Family Health International | North Carolina | 91 | $2.1 billion |
| Catholic Relief Services - United States Conference of Catholic Bishops | Maryland | 128 | $1.2 billion |
| Save the Children Federation, Inc. | Connecticut | 100 | $814 million |
| Research Triangle Institute | North Carolina | 33 | $756 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFI-621-21-HO-001 still open?
No. It closed on September 15, 2021.
Who can apply for Tanzania Malaria Case Management Activity (TMCM)?
Tanzania USAID-Dar es Salaam accepted applications from any type of organization.
What is the deadline for Tanzania Malaria Case Management Activity (TMCM)?
Closed September 15, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $45.0 million in total for one award.
Who has won USAID Foreign Assistance for Programs Overseas grants before?
The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)